Global Active Pharmaceutical Ingredients (API) Market Size By Chemical Class (Anti-Infective, Peptides), By Molecule Type (Small Molecule, Large Molecule), By Therapeutic Area (Cardiovascular, Oncology), By Geographic Scope And Forecast

Active Pharmaceutical Ingredients (API) Market Size And Forecast

Active Pharmaceutical Ingredients (API) Market size was valued at USD 192,462.34 Million in 2023 and is projected to reach USD 336,233.71 Million by 2030, growing at a CAGR of 7.18% from 2024 to 2030.

The growing pharmaceutical industry and the escalating incidence of chronic disorders are the factors driving the market growth. The Global Active Pharmaceutical Ingredients (API) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Active Pharmaceutical Ingredients (API) Market Definition

An Active Pharmaceutical Ingredient (API) is a component used to manufacture pharmaceutical medications that play an essential role in their therapeutic efficacy. An API, often known as a drug substance, is the physiologically active pharmaceutical component responsible for its pharmacological effects. The central component delivers the desired therapeutic activity, whether symptom relief, disease cure, or disease management. APIs can be taken from various sources, including natural substances such as plants, animals, and minerals, or they can be synthesized chemically. Regardless of origin, APIs must meet high purity, quality, and efficacy standards to assure the safety and effectiveness of the pharmaceutical product.

API creation and production entail complicated phases, beginning with research and discovery and ending with manufacturing and quality control. Researchers find promising APIs in the early phases of medication development by thoroughly examining biological and chemical features. Once a promising molecule is identified, it is tested extensively to determine its safety and efficacy. If the compound is a promising contender, it advances to the manufacturing phase, when large-scale manufacturing procedures are built. API synthesis may require complex chemical operations, extraction from natural sources, or combining the two.

Global Active Pharmaceutical Ingredients (API) Market Overview

The “Global Active Pharmaceutical Ingredients (API) Market” has been driven by factors such as the expanding world population and the rise in the frequency of different ailments. The requirement for APIs to create potent drugs develops in tandem with the demand for pharmaceuticals. The rising prevalence of chronic diseases is a crucial driver of the Active Pharmaceutical Ingredients (API) Market’s rapid expansion, etc. However, the lack of innovation in some therapeutic regions is a significant barrier that may hamper the market growth in the near future. rising popularity of personalized medicine and precision therapeutics is a vital and revolutionary trend in the Active Pharmaceutical Ingredients (API) Market is becoming a key trend in the global market.

Cardiovascular illnesses, diabetes, respiratory disorders, and certain types of cancer are examples of chronic disorders, which are defined by long-term and persistent health concerns. As the world’s population ages and lifestyle factors increase the prevalence of these ailments, the demand for pharmacological treatments to manage and cure chronic disorders has increased, supporting the expansion of the Active Pharmaceutical Ingredients (API) Market. One of the key elements driving this expansion is the need for novel and effective treatments to suit the different demands of people dealing with chronic health concerns.

Global Active Pharmaceutical Ingredients (API) Market Segmentation Analysis

The Global Active Pharmaceutical Ingredients (API) Market is Segmented on the basis of Chemical Class, Molecule Type, Therapeutic Area, and Geography.

Active Pharmaceutical Ingredients (API) Market, By Chemical Class

• Anti-infective
  1. Antibiotics
  2. Others
• Peptides
• Steroids

To Get a Summarized Market Report By Chemical Class-

Based on Chemical Class, the market is Segmented into Anti-infective, Peptides, and Steroids. The Global Active Pharmaceutical Ingredients (API) Market is experiencing a scaled level of attractiveness in the “Anti-infective” segment. Anti-infective accounted for the largest market share of 37.41% in 2022, with a market value of USD 71,994.38 Million, and is projected to grow at the highest CAGR of 7.63% during the forecast period. Peptides was the second-largest market in 2022, valued at USD 46,445.75 Million in 2022; it is projected to grow at a CAGR of 7.28%.

Anti-infective APIs are a collection of APIs that are capable of killing infectious organisms entirely or hindering the growth of these infectious organisms. This term comprises antimalarial, antibiotics, antivirals, antifungals, antituberculosis, anthelmintics, and antiprotozoals. Infection can be bacterial, viral, fungal, and parasitic infection. Anti-infectives have entirely changed the healthcare industry and are essential for treating and preventing many infections. Ant-infective API treats minor infections cures severe infectious diseases, and gives vital immune suppressive treatment to cancer patients.

Active Pharmaceutical Ingredients (API) Market, By Molecule Type

• Small Molecule
• Large Molecule

To Get a Summarized Market Report By Molecule Type-

Based on Molecule Type, the market is Segmented into Small Molecule and Large Molecule. The Global Active Pharmaceutical Ingredients (API) Market is experiencing a scaled level of attractiveness in the Small Molecule segment. Small Molecule accounted for the largest market share of 59.51% in 2022, with a market value of USD 114,526.59 Million, and is projected to grow at the highest CAGR of 7.62% during the forecast period. Large Molecule was the second-largest market in 2022, valued at USD 77,935.75 Million in 2022; it is projected to grow at a CAGR of 6.50%.

The primary factors propelling the small molecule API are the increasing incidence of illnesses such as cancer, heart disease, and infections; the establishment of companies manufacturing small molecule APIs; and the expiration of patents on the most popular pharmaceuticals. Growing corporate partnerships, easy access to medicine in developing nations, and growing consumer awareness of the benefits of small-molecule Active Pharmaceutical Ingredients (APIs) are driving the growth of the small-molecule API.

The growing prevalence of generic medications and the increased manufacturing sector production of small molecule APIs due to technological improvements impact the small molecule Active Pharmaceutical Ingredients (API) Market. Moreover, the growing elderly population, increased awareness of diseases and their treatments, research and development efforts, better healthcare infrastructure, and rising healthcare costs all positively affect the small molecule Active Pharmaceutical Ingredients (API) Market.

Active Pharmaceutical Ingredients (API) Market, By Therapeutic Area

• Cardiovascular
• Oncology
• Central Nervous System
• Infectious Diseases
• Metabolic Disorders
• Autoimmune Disorders
• Others

To Get a Summarized Market Report By Therapeutic Area-

Based on Therapeutic Area, the market is Segmented into Cardiovascular, Oncology, Central Nervous System, Infectious Diseases, Metabolic Disorders, Autoimmune Disorders, and Others. The Global Active Pharmaceutical Ingredients (API) Market is experiencing a scaled level of attractiveness in the Cardiovascular segment. Cardiovascular accounted for the largest market share of 21.43% in 2022, with a market value of USD 41,249.91 Million, and is projected to grow at the highest CAGR of 8.14% during the forecast period. Oncology was the second-largest market in 2022, valued at USD 36,741.94 Million in 2022; it is projected to grow at a CAGR of 7.41%.

The term “cardiovascular API” describes the active component or material in a medication specially made to treat cardiovascular conditions. These APIs can be found in several drugs that treat diseases like lipid disorders, heart failure, and high blood pressure. Cardiovascular APIs can be found in various chemical classes, each with a unique mechanism of action to treat different facets of cardiovascular health.

One of the main factors propelling the cardiovascular Active Pharmaceutical Ingredients (API) Market is the increasing incidence of cardiovascular illnesses, such as heart failure, coronary artery disease, and hypertension. There is an increasing need for pharmacological therapies to control and treat cardiovascular illnesses due to the global prevalence of these conditions. The aging population is a contributing factor to the rise in cardiovascular disease incidence, particularly in wealthy nations. The need for cardiovascular APIs is fueled by the fact that older people frequently need pharmaceutical therapies to address cardiovascular risk factors and diseases.

Active Pharmaceutical Ingredients (API) Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on Regional Analysis, the Global Active Pharmaceutical Ingredients (API) Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The Global Active Pharmaceutical Ingredients (API) Market is experiencing a scaled level of attractiveness in the Asia Pacific region. North America accounted for the largest market share of 34.28% in 2022, with a market value of USD 65,976.09 Million, and is projected to grow at a CAGR of 7.15% during the forecast period. Europe was the second-largest market in 2022, valued at USD 56,603.17 Million in 2022; it is projected to grow at a CAGR of 6.87%. However, Asia-Pacific is projected to grow at the highest CAGR of 7.75%.

The surge in chronic diseases across the Asia-Pacific region has created an escalating demand for pharmaceuticals, consequently driving the need for active pharmaceutical ingredients (APIs). With a growing incidence of chronic conditions, there is an imperative requirement for a consistent supply of medications. This trend is reflected in statistics revealing a substantial increase in the prevalence of chronic diseases in the region, underscoring the critical role of APIs in meeting the pharmaceutical demands associated with addressing these health challenges. For instance, as per a report published by the OECD, Cardiovascular Diseases is a leading cause of death in the Asia Pacific region, with more than 9 million deaths yearly. The key factors driving this rising prevalence are lack of physical activity, obesity, high blood pressure, tobacco consumption, etc. Additionally, the ongoing advancements in pharmaceutical manufacturing technologies and processes are anticipated to contribute to the region’s competitiveness in producing high-quality APIs.

Key Players

The major players in the market include Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis AG, Merck, Sanofi, Boehringer Ingelheim International GmbH, Lonza, Dr.Reddy’s laboratory, Aurobindo Pharma Limited, Cipla Limited, and others. This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with Coating Type benchmarking and SWOT analysis.

Key Developments

• In October 2023, Merck Strengthened its Oncology pipeline through a strategic partnership with Hengrui for next-generation selective PARP1 inhibitor and antibody-drug conjugate.
• In February 2020, Sanofi created an industry-leading European company to provide Active Pharmaceutical Ingredients (API). The idea was to establish a stand-alone business that would incorporate Sanofi’s six European API production locations—Brindisi, Italy; Frankfurt, Germany; Haverhill, UK; St. Aubin les Elbeuf, France; Öjpest, Hungary; and Vertolaye, France and its commercial and development activities.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

<a href="https//www.marketresearch.com/wp-content/uploads/2022/11/Ace-Matrix-Analysis-of-Active-Pharmaceutical-Ingredient-API-Market-1.webp" rel="noopener" target="_